Taika Capital LP Buys Shares of 8,975 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Taika Capital LP bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,975 shares of the medical equipment provider’s stock, valued at approximately $4,685,000. Intuitive Surgical comprises 3.6% of Taika Capital LP’s portfolio, making the stock its 8th biggest holding.

Other hedge funds also recently made changes to their positions in the company. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $31,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Finally, Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $36,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,579 shares of company stock worth $7,756,844. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ISRG. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG opened at $518.26 on Monday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a market cap of $184.59 billion, a PE ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43. The stock has a 50-day moving average of $571.36 and a 200-day moving average of $531.85.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.